Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("COLER, Rhea N")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 25

  • Page / 1
Export

Selection :

  • and

Second-generation vaccines against leishmaniasisCOLER, Rhea N; REED, Steven G.Trends in parasitology. 2005, Vol 21, Num 5, pp 244-249, issn 1471-4922, 6 p.Article

Bioinformatic identification of tandem repeat antigens of the Leishmania donovani complexGOTO, Yasuyuki; COLER, Rhea N; REED, Steven G et al.Infection and immunity. 2007, Vol 75, Num 2, pp 846-851, issn 0019-9567, 6 p.Article

Leish-111f, a recombinant polyprotein vaccine that protects against visceral leishmaniasis by elicitation of CD4+ T cellsCOLER, Rhea N; GOTO, Yasuyuki; BOGATZKI, Lisa et al.Infection and immunity. 2007, Vol 75, Num 9, pp 4648-4654, issn 0019-9567, 7 p.Article

Protective immunization against visceral leishmaniasis using Leishmania sterol 24-c-methyltransferase formulated in adjuvantGOTO, Yasuyuki; BOGATZKI, Lisa Y; BERTHOLET, Sylvie et al.Vaccine. 2007, Vol 25, Num 42, pp 7450-7458, issn 0264-410X, 9 p.Article

Immunologic correlates of protection and potential role for adjuvants to improve influenza vaccines in older adultsMCELHANEY, Janet E; COLER, Rhea N; BALDWIN, Susan L et al.Expert review of vaccines. 2013, Vol 12, Num 7, pp 759-766, issn 1476-0584, 8 p.Article

Cloning, characterization, and serodiagnostic evaluation of Leishmania infantum tandem repeat proteinsGOTO, Yasuyuki; COLER, Rhea N; GUDERIAN, Jeffrey et al.Infection and immunity. 2006, Vol 74, Num 7, pp 3939-3945, issn 0019-9567, 7 p.Article

Increased potency of an inactivated trivalent polio vaccine with oil-in-water emulsionsBALDWIN, Susan L; FOX, Christopher B; PALLANSCH, Mark A et al.Vaccine. 2011, Vol 29, Num 4, pp 644-649, issn 0264-410X, 6 p.Article

Immunotherapy for drug-refractory mucosal leishmaniasisBADARO, Roberto; LOBO, Iza; MUNOS, Alvaro et al.The Journal of infectious diseases. 2006, Vol 194, Num 8, pp 1151-1159, issn 0022-1899, 9 p.Article

A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1 + MPL-SE vaccine when used in combination with sodium stibogluconate for the treatment of mucosal leishmaniasisLLANOS-CUENTAS, Alejandro; CALDERON, Wessmark; BECKMANN, Anna Marie et al.Vaccine. 2010, Vol 28, Num 46, pp 7427-7435, issn 0264-410X, 9 p.Article

A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1 + MPL-SE vaccine for use in the prevention of visceral leishmaniasisCHAKRAVARTY, Jaya; KUMAR, Subodh; COWGILL, Karen D et al.Vaccine. 2011, Vol 29, Num 19, pp 3531-3537, issn 0264-410X, 7 p.Article

Optimized subunit vaccine protects against experimental leishmaniasisBERTHOLET, Sylvie; GOTO, Yasuyuki; CARTER, Lauren et al.Vaccine. 2009, Vol 27, Num 50, pp 7036-7045, issn 0264-410X, 10 p.Article

Identification and characterization of novel recombinant vaccine antigens for immunization against genital Chlamydia trachomatisCOLER, Rhea N; BHATIA, Ajay; METTENS, Pascal et al.FEMS immunology and medical microbiology (Print). 2009, Vol 55, Num 2, pp 258-270, issn 0928-8244, 13 p.Article

Immunisation with ID83 fusion protein induces antigen-specific cell mediated and humoral immune responses in cattleJONES, Gareth J; STEINBACH, Sabine; CLIFFORD, Derek et al.Vaccine. 2013, Vol 31, Num 45, issn 0264-410X, S250-S255Article

Protection of mice from Mycobacterium tuberculosis by ID87/GLA-SE, a novel tuberculosis subunit vaccine candidatePLESSNER WINDISH, Hillarie; DUTHIE, Malcolm S; IRETON, Greg et al.Vaccine. 2011, Vol 29, Num 44, pp 7842-7848, issn 0264-410X, 7 p.Article

A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1 + MPL-SE vaccine when used in combination with meglumine antimoniate for the treatment of cutaneous leishmaniasisNASCIMENTO, Evaldo; FERNANDES, Demetrios F; PINE, Samuel O et al.Vaccine. 2010, Vol 28, Num 40, pp 6581-6587, issn 0264-410X, 7 p.Article

Enhanced humoral and Type 1 cellular immune responses with Fluzone® adjuvanted with a synthetic TLR4 agonist formulated in an emulsionBALDWIN, Susan L; SHAVERDIAN, Narek; REED, Steven G et al.Vaccine. 2009, Vol 27, Num 43, pp 5956-5963, issn 0264-410X, 8 p.Article

Intradermal immunization improves protective efficacy of a novel TB vaccine candidateBALDWIN, Susan L; BERTHOLET, Sylvie; KAHN, Maria et al.Vaccine. 2009, Vol 27, Num 23, pp 3063-3071, issn 0264-410X, 9 p.Article

Transcriptional profiling of TLR-4/7/8-stimulated guinea pig splenocytes and whole blood by bDNA assayCHING, Lance K; MOMPOINT, Farah; GUDERIAN, Jeffrey A et al.Journal of immunological methods. 2011, Vol 373, Num 1-2, pp 54-62, issn 0022-1759, 9 p.Article

Leishmania infantum sterol 24-c-methyltransferase formulated with MPL-SE induces cross-protection against L. major infectionGOTO, Yasuyuki; BHATIA, Ajay; RAMAN, Vanitha S et al.Vaccine. 2009, Vol 27, Num 21, pp 2884-2890, issn 0264-410X, 7 p.Article

Immunization with a polyprotein vaccine consisting of the T-cell antigens thiol-specific antioxidant, Leishmania major stress-inducible protein 1, and Leishmania elongation initiation factor protects against leishmaniasisCOLER, Rhea N; SKEIKY, Yasir A. W; BERNARDS, Karen et al.Infection and immunity. 2002, Vol 70, Num 8, pp 4215-4225, issn 0019-9567, 11 p.Article

Therapeutic Immunization against Mycobacterium tuberculosis Is an Effective Adjunct to Antibiotic TreatmentCOLER, Rhea N; BERTHOLET, Sylvie; PINE, Samuel O et al.The Journal of infectious diseases. 2013, Vol 207, Num 8, pp 1242-1252, issn 0022-1899, 11 p.Article

TLR4 ligand formulation causes distinct effects on antigen-specific cell-mediated and humoral immune responsesFOX, Christopher B; MOUTAFTSI, Magdalini; VERGARA, Julie et al.Vaccine. 2013, Vol 31, Num 49, pp 5848-5855, issn 0264-410X, 8 p.Article

Safety and immunogenicity of a defined vaccine for the prevention of cutaneous leishmaniasisVELEZ, Iván D; GILCHRIST, Katherine; COWGILL, Karen D et al.Vaccine. 2010, Vol 28, Num 2, pp 329-337, issn 0264-410X, 9 p.Article

Protective efficacy of a tandemly linked, multi-subunit recombinant leishmanial vaccine (Leish-111f) formulated in MPL® adjuvantSKEIKY, Yasir A. W; COLER, Rhea N; BRANNON, Mark et al.Vaccine. 2002, Vol 20, Num 27-28, pp 3292-3303, issn 0264-410X, 12 p.Article

Protection against cutaneous leishmaniasis induced by recombinant antigens in murine and nonhuman primate models of the human diseaseCAMPOS-NETO, Antonio; PORROZZI, Renato; GREESON, Kay et al.Infection and immunity. 2001, Vol 69, Num 6, pp 4103-4108, issn 0019-9567Article

  • Page / 1